HollowMan
Harmless
Posts: 43
Registered: 10-12-2013
Member Is Offline
Mood: No Mood
|
|
DMT via tryptamine and NaBH4
Hi,
I just found this interesting method for synthesis DMT by using tryptamine and NaBH4 as a starting material. Usually NaBHCN is used as reducing agent.
So did anyone this route successfully?
Successful synthesis, reduced yields.
(Rated as: pretending illegal activity)
The synthesis outlined in the message 'NaBH4 in water' was attempted as follows (1/4 scale):
A solution of 37% formaldehyde in H2O (8.6 mL, 104 mmol) in MeOH (9.5 mL) and a solution of NaBH4 (1.25 g, 33 mmol) in H2O (17.5 mL) were added
dropwise, simultaneously, at 15°C to a well-stirred solution of tryptamine (1.06 g, 6.5 mmol) in MeOH (37.5 mL). The mixture was stirred at 15°C for
0.5 h, 6N aqueous HCl was cautiously added to bring the pH to 3.02, and the resulting mixture was stirred for 10 min. Then, the pH was adjusted to
6.5-7 with saturated aqueous NaHCO3, MeOH was evaporated on the rotovap, and H2O (12 mL) was added. The mixture was washed with EtOAc (2x37.5 mL),
basified to pH 10.4 with K2CO3, and extracted with EtOAc (2x32.5 mL). The organic extracts were dried, over K2CO3, vacuum filtered, and EtOAc
evaporated to give DMT. Products were obtained in (1) 0.46 g (2.44 mmol 37.6 % yield) and (2) 0.58 g (3 mmol, 46% yield).
Results: The entire process was completed twice, T1 and T2. Two differences existed between these trials. In T1 the simultaneous addition of NaBH4
and formaldehyde was rapid (ca. 2 minutes), whereas in T2 the addition took at least 7 minutes. In T1 the rotovap step was minimised to 45 minutes,
whereas in T2 it was 1.5 hours.
The T1 product was crystalline, whereas the T2 product was an oil that solidified upon freezing and repeated collection with a razor in the
evaporating dish. Both products were analyzed with GC-MS. Positive identification of the N,N-DMT product was established by comparing the spectrum
with a reference from http://spectra.galactic.com/. Molecular ion peak is present at 188 m/z, with the largest peak at 58 m/z. The T1 product was 99.0% pure (by
integration), whereas the T2 product was 91.6% pure. The T2 sumultaneous addition of reagents was executed with more precision than the T1, so it is
probable that the longer rotovap time was responsible for the lower purity.
The T1 product was, in addition, analyzed with 1H NMR, in d-acetone, 300 MHz. The indole region from 7-9 ppm was unchanged from the tryptamine
starting material. However, the production of N,N-DMT was supported by appearance of two triplets between 2 and 3 ppm (corresponding to the CH2) and
a singlet at slightly under 2 ppm (corresponding to the double methylation). Integration of the singlet was 6 units, and each triplet 2 units.
This procedure shows promise...good yield can be obtained (46%) even in sub-optimal conditions. Furthermore, reagents are easy to obtain, and are
inexpensive.
Some developments might include finding a way to avoid the rotovap step, since this appears to have an adverse effect on product purity. Instead
of dissolving the tryptamine in MeOH, H2O will be used as solvent in a future trial. It is interesting to note that the original paper
Tetrahedron 57(6), 1041-1048 (2001) https://www.rhodium.ws/pdf/tryptamine.nabh4.methylation.pdf
reports yields of 80-90%. The difference between that procedure and this present one is a large sulfur-containing group at the 4-position on the
benzene ring. Could this have activating effects that are not seen when the ring is unsubstituted?
Maybe the best conclusion to make from this venture is that individuals could do well to give up the difficult and time-consuming
bromination/methylation/reduction procedures (eg. NaBH4 reduction of Keto-DMT thread), if the goal is production and not chemistry games. This
procedure takes a total of 3.5 hours, does not depend on dry solvents, uses only one nasty reagent (formaldehyde), and costs very little. If the
trial with water as solvent instead of methanol is successful, then 45 minutes will be taken off preparation time, and the rotovap step will be
avoided. Product purity is generally high. But even when compromised (91.6%), the contaminants were identfied as N-methyltryptamine and unreacted
tryptamine, so there is low potential for toxic byproducts or retention of formaldehyde.
https://the-hive.archive.erowid.org/forum/showflat.pl?Number...
|
|
tsathoggua1
Hazard to Others
![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif)
Posts: 335
Registered: 8-1-2017
Location: Beyond the pale
Member Is Offline
Mood: Phosphorescent
|
|
Looks a lot like the Eschweiler-Clarke, only using HCl instead of HCOOH. I'm dubious about this at best. Although if its been done and reported in a
respectable journal with proper analysis my skepticism will have to take a back seat.
Its just that its been well known for quite some time that the Eschweiler-Clarke won't work on tryptamine because the primary reaction is toward
formation of an unwanted side-product, cyclization to the corresponding beta-carboline.
Now. Keto-DMT. Is this beta-keto-DMT being spoken of? that would be a curious one to bioassay indeed, to compare the tryptamine and cathinone
pharmacophores.
IIRC, it might not have the expected activity. Or at least, it might have some rather unexpected properties. I recall reading that some of the
indoleglyoxylamides were GABAa agonists (probably meaning positive allosteric modulator, given the relatively restrictive requirements structurally
for a muscimol-like orthosteric agonist.
|
|
Crowfjord
Hazard to Others
![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif)
Posts: 390
Registered: 20-1-2013
Location: Pacific Northwest
Member Is Offline
Mood: Ever so slowly crystallizing...
|
|
It's a reductive amination, with sodium borohydride instead of formic acid as the reductant. Compared to Eschweiler-Clarke, that is. The procedure
looks like one in a paper concerning synthesis of rizatriptan starting with tryptamine. I'll attach the paper and supplementary materials, which
contain the actual experimental procedure.
Tetrahedron Letters 55 (2014) 3938-3941
Attachment: Synthesis of Rizatriptan.pdf (607kB) This file has been downloaded 673 times
Attachment: Synthesis of Rizatriptan (Supplementary material).doc (2.8MB) This file has been downloaded 592 times
|
|
HollowMan
Harmless
Posts: 43
Registered: 10-12-2013
Member Is Offline
Mood: No Mood
|
|
@ Crowfjord
Where did you found this files?
Sth what is missing in the procedure is the actual addition time of the formaldehyde/NaBH4 solution. As I know, it is pretty difficult to stay at
15°C because the reaction is very exothermic.
There are some futher differences between your files and the Hive introduction. Especially in the cleaning procedure. In the patent everything after
the addition is just made basic and than extracted. In the other one he made it acidic before ( maybe to destroy remaining NaBH4?) and than adjusted
the ph to 7 before evaporation of the MeOH. This makes no sense for me because why not just evaporating the MeOH in acidic conditions and after the
extraction with EtOAc?
In the patent there is no washing with EtOAc before making basic. Instead of this, the crude product is recrystallized with EtOAc:Hepatane in 5:1
ratio.
Usually DMT is recrystallized in Heptane/Naphta. So why using this ratio? EtOAc:Hepatane 1:5 would make much more sense to me, because usually
everything is soluble in EtOAc in really less amounts.
Anyone knows, why using EtOAc for this extraction? The problem of EtOAc is the pretty good water solubility (80 g/L) so a lot of water is remaining in
the extract.
What could be used instead?
|
|
HollowMan
Harmless
Posts: 43
Registered: 10-12-2013
Member Is Offline
Mood: No Mood
|
|
And Tetrahedron original paper says -15°C instead of 15°C. Isn´t NaBH4 reacting much to slow at -15°C?
Tetrahedron:
http://chemistry.mdma.ch/hiveboard/rhodium/pdf/tryptamine.na...
|
|
clearly_not_atara
International Hazard
![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif)
Posts: 2725
Registered: 3-11-2013
Member Is Offline
Mood: Big
|
|
The use of a very slow reaction at low temperatures is indicated in this case to prevent Pictet-Spengler cyclization of the intermediate. However,
it's not clear why this topic has been permitted on this forum, considering it clearly violates the rules about drug synthesis.
|
|
Texium
Administrator
![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif) ![*](images/xpblue/star.gif)
Posts: 4547
Registered: 11-1-2014
Location: Salt Lake City
Member Is Offline
Mood: PhD candidate!
|
|
Must have missed this one.
|
|
Texium
|
Thread Moved 9-8-2017 at 17:24 |
Bert
|
Thread Moved 16-11-2017 at 07:32 |